Welcome to the 5th Annual Gene Therapy Analytical Development Summit 2023

Develop, Validate & Implement Robust Analytical Tools to Guarantee Safety, Efficacy, Quality, & Consistency of Gene Therapy Products

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.

In this context, the 5th Annual Gene Therapy Analytical Development is returning in 2023, uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality, consistency, safety, and efficacy of gene therapy products.

Join biopharma colleagues specializing in bioassays, molecular biology, physicochemical properties, quality, process development and regulation across 4 days of niche, expert presentations, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer, efficacious therapies to patients more quickly and effectively.


Previously Attending Companies Include:

GTx -216n
GTx -002n
GTx -116n

World-Class Speaker Faculty Includes:

Arun Rooj

Associate Director, Gene Therapy Analytical Development

Sarepta Therapeutics

Bartlomieg Blus

Bartlomiej Blus

Associate Director, Group Leader

Biomarin Pharmaceuticals


George Bou-Assaf

Associate Director, Analytical & Biophysical Development


Marina Feschenko

Marina Feschenko

Senior Director, Analytical Development, Cell & Gene Therapy

Vertex Pharmaceuticals

Sarah Wassmer

Quality , Cells, Gene Therapies & Radiopharmaceuticals Division Evaluator

Health Canada

Ting He

Senior Scientist, AAV Pharmaceutical Development

Ultragenyx Pharmaceuticals

Vinay Kondeti

Senior Scientist

BridgeBio Gene Therapy

Wei Cao

Analytical Program Development and Management

Spark Therapeutics

Yixin Li

Principal Scientist

Adverum Biotechnologies

Zhenhong Li

Executive Director, Analytical Development & Quality Control

Passage Bio

GTAD was my favorite conference I attended all last year by far! It strikes a great balance between broadness and the topics being narrow enough that all attendees are very engaged. As an attendee this means all the talks are interesting and relevant to my work. As a speaker this means an engaged audience with insightful questions and valuable feedback.

2022 Attendee, Sanofi


2023 Senior Partners:

Screenshot (331)

Download the Full Event Guide for more information on:

    • Expert Speaker Faculty
    • Full Access to the 4-Day Conference Agenda
    • Audience Breakdown
    • & more